Switch View
© Globe Newswire
11.09.2025
ISIN: US75383L1026
Rapport Therapeutics Inc.
RAPP
LISTED
NASDAQ
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
News Preview
BOSTON and SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that management plans to p...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US0050831009
Actuate Therapeutics, Inc.
ACTU
LISTED
NASDAQ
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
News Preview
CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
News Preview
Company announcement – No. 20 / 2025...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
11.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”), have until November 10, 2025 to seek appointment as lead plaintiff of the Lantheus class action lawsuit. Captioned Margolis v....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
11.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors with Losses in Excess of $100K Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Kuehn Law Encourages Investors of DexCom, Inc. to Contact Law Firm
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shareholders.
A...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages Savara Inc. (SVRA) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) securities between March 7, 2024 and May 23, 2025, inclusive (the “Class Period”). Savara investors have until November 7, 2025 to file a lead plaintiff motion.
IF YOU ARE...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”). Unicycive is a clinical-stage biotechnology company.
For more information, s...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: VGG1110E1079
Biohaven Ltd
BHVN
LISTED
NYSE
Deadline Soon: Biohaven Ltd. (BHVN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming September 12, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025, inclusive (the “Class P...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US70805E1091
Pennant Group Inc
PNTG
LISTED
NASDAQ
Pennant Group to Participate in the 2025 Jefferies Healthcare Services Conference
News Preview
Pennant to participate in Jefferies Healthcare Services Conference...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Rosen Law Firm Urges Lantheus Holdings, Inc. (NASDAQ: LNTH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025. Lantheus describes itself as a “global company that develops, manufactures, sells, and distributes certain diagnostic and...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: DK0060055861
Chemometec A/S
CHEMM
LISTED
CPH
Annual Report 2024/25 - Growing revenue and EBITDA
News Preview
ANNOUNCEMENT NO. 292...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
11.09.2025
ISIN: DK0060055861
Chemometec A/S
CHEMM
LISTED
CPH
Guidance for the 2025/26 financial year
News Preview
ANNOUNCEMENT NO. 291...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CA68405U1012
Optimind Pharma Corp.
OMND
LISTED
CSE
CSE Bulletin: Halted for Fundamental Change - Optimind Pharma Corp. (OMND)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 11 septembre/September 2025) - Trading in the shares of Optimind Pharma Corp. (OMND) will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant to CSE Policy 8. This regulatory halt is imposed by Canadian Investment Regulatory Organization, th...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.09.2025
ISIN: US60785L2079
Modular Medical, Inc.
MODD
LISTED
NASDAQ
Modular Medical Announces Completion of Clinical Study of MODD1 Pump
News Preview
- Use of MODD1 on clinicians with Type 1 diabetes SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target the estimated $3 billion dollar adult &quo...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly to participate in Bernstein's 2nd Annual Healthcare Forum
News Preview
INDIANAPOLIS, Sept. 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025. Lucas Montarce, executive vice president and chief financial officer, will take part in a fireside chat at 8 a.m., Eastern time.
A live audio webcast will be available on the "Webcas...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
Ipsen - August 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
News Preview
Monthly information relative to the total number of voting rights and shares composing the share capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer
News Preview
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025
News Preview
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
News Preview
SALT LAKE CITY, Sept. 11, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has performed an in silico analysis of the primers sets used in its Co-Primers®-based PCR tests f...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US30048L3024
Evofem Biosciences, Inc
EVFM
LISTED
OTC
Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms
News Preview
-- 130% increase in traffic to PHEXXI.com, the website for Evofem's hormone-free prescription contraceptive PHEXXI® (lactic acid citric acid and potassium bitartrate) --
-- PHEXXI® is #1 most followed contraceptive brand on social media by healthcare providers --
SAN DIEGO, Sept. 11, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (Evofem) (OTCID:...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the closing of its previously announced underwritten public offering of 28,750,000 shares of its common stock, i...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US92532F1003
Vertex Pharmaceuticals Inc
VRTX
LISTED
NASDAQ
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis
News Preview
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year’s Lasker~DeBakey Clinical Medical Research Award for his role “in the development of a novel, life-saving treatment for cystic fibrosis (CF) — namely, a triple-drug combination therapy, TRIK...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US45784A1043
InnovAge Holding Corp
INNV
LISTED
NASDAQ
InnovAge Named as One of the Nation’s Best Workplaces in Aging Services™ by Fortune® and Great Place to Work®
News Preview
InnovAge named a top 15 Best Workplace in Aging Services by Fortune & Great Place to Work®, honoring its culture of care and dedicated PACE team....
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit Awarded Major National Tender in France, Expanding Access to Breast AI in Public Hospitals
News Preview
Framework agreement with UniHA enables access to Lunit's breast AI solutions across 1,500+ French public hospitals, in collaboration with Fujifilm
SEOUL, South Korea, Sept. 11, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that its breast imaging AI solutions have bee...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025
News Preview
Press release – No.13 / 2025...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CA65347A1021
Nextleaf Solutions Ltd.
OILS
LISTED
CSE
Nextleaf Provides Strategic Update: Canada's First 200-Pack Cannabis Softgels, and Opening of Distribution Facility
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science company and licensed cannabis processor announces the launch of Canada's first 200-pack cannabis softgels under its house brand Glacial GoldT...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CA88410L1022
Thiogenesis Therapeutics, Corp.
TTI
LISTED
TSX
Thiogenesis Reports on 2025 Annual General Meeting of Shareholders and Provides Corporate Update
News Preview
San Diego, California--(Newsfile Corp. - September 11, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biopharmaceutical company developing sulfur-based therapeutics for serious pediatric diseases, today announced the results of its Annual General Meeting of Shareholders ("AGM")...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Class Action: The Gross Law Firm Reminds Semler Scientific, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 - SMLR
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders who purchased shares of SMLR during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Investors who lost money on LifeMD, Inc.(LFMD) should contact The Gross Law Firm about pending Class Action - LFMD
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased shares of LFMD during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
October 21, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NUTX
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purchased shares of NUTX during the class period listed are encouraged to...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
NEOG LAWSUIT ALERT: The Gross Law Firm Notifies Neogen Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neogen Corporation (NASDAQ: NEOG).
Shareholders who purchased shares of NEOG during the class period listed are encouraged t...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL LAWSUIT ALERT: The Gross Law Firm Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL).
Shareholders who purchased shares of REPL during the class period listed are encourage...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) should contact The Gross Law Firm about pending Class Action - ANRO
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO).
Shareholders who purchased shares of ANRO during the class period listed are encourage...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 6, 2025 to Discuss Your Rights - ALT
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Investors in Unicycive Therapeutics, Inc. Should Contact The Gross Law Firm Before October 14, 2025 to Discuss Your Rights - UNCY
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY).
Shareholders who purchased shares of UNCY during the class period listed are en...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights - CAPR
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR).
Shareholders who purchased shares of CAPR during the class period listed are enc...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RxSight, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - RXST
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST).
Shareholders who purchased shares of RXST during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN).
Shareholders who purchased shares of BHVN during the class period listed are encouraged to conta...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US2666055007
DURECT Corp
DRRX
LISTED
NASDAQ
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
News Preview
The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline
LAVAL, QC, and CUPERTINO, Calif., Sept. 11, 2025 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC) ("Bausch Health"), a global, diver...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US6373722023
National Research Corp
NRC
LISTED
NASDAQ
NRC Health Welcomes South Shore Health to Advance Patient and Employee Experience
News Preview
NRC Health is proud to welcome South Shore Health as its newest partner in healthcare experience excellence. This strategic collaboration reflects South Shore’s commitment to advancing patient and employee experience through innovative, human-centered solutions and a trusted support model.
This press release features multimedia. View the full rel...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Announces Pricing of Secondary Offering of Common Stock
News Preview
LEHI, Utah, and LOUISVILLE, Ky., Sept. 11, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced the pricing of the previously announced underwritten secondary offering by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: CA13509T1057
MTL Cannabis Corp.
MTLC
LISTED
CSE
MTL Cannabis Corp. Expands Global Reach with Launch of Branded Products into Australian Medical Market
News Preview
PICKERING, ON, Sept. 11, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) ("MTL" or the "Company") is pleased to announce the official launch of its premium branded cannabis products into the rapidly growing Australian medical market....
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform. This update allows the generation of T1 and T2 inline maps, further enh...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US69380Q1076
PACS Group, Inc.
PACS
LISTED
NYSE
PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics
News Preview
PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), on September 10, 2025, announced that on September 9, 2025, the New York Stock Exchange (“NYSE”) Listing Operations Committee agreed to provide the Company with an additional trading period through November 19, 2025, subject to its ongoing review of the Company. The additional trading period...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it has reached a strategic agreement with LabFlorida/SunDx Labs to provide residents of senior living communities access to Guardant Shield™, the first blood test approved by the U.S. Food and Drug Administration (FDA) as a primary screening option for colore...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US48301N1046
Kairos Pharma Ltd
KAPA
LISTED
XASE
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
News Preview
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that it will host a premier KOL event on Thursday, Sept. 18th at 5 p.m. ET / 2 p.m. PT to discuss diverse perspectives on the Company’s interim efficacy results from a Phase 2 trial of its lead candidate,...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) has recently announced two strategic collaborations across its contract development and manufacturing organization (CDMO), aimed at advancing novel oncology research and development. These collaborations include forming an alliance with the Parker Institute for Cancer Immunotherapy and sup...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
Masimo Announces Expansion of Strategic Partnership with Philips
News Preview
Masimo (NASDAQ: MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG, AEX: PHIA).
Building on over two decades of collaboration, this significant partnership expansion is designed to accelerate the integration of Masimo’s monitoring technologies, such as industry-leading SET® pulse o...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US04280A1007
Arrowhead Pharmaceuticals Inc
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis Pharmaceuticals
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that yesterday it filed a Complaint for Declaratory Judgment in the United States District Court for the District of Delaware against Ionis Pharmaceuticals, Inc., to declare that Ionis’s United States Patent No. 9,593,333 (“the ’333 patent”) is invalid and not infringed by Arrowhead’s...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US5526411021
MAIA Biotechnology Inc
MAIA
LISTED
XASE
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
News Preview
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today highlighted positive efficacy data from its Phase 2 clinical trial, THIO-101, evaluating ateganosine (THIO) sequenced with t...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: KYG1281K1067
Silexion Therapeutics Corp
SLXN
LISTED
NASDAQ
Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering
News Preview
Grand Cayman, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the pricing of a public offering of an aggregate of 1,500,000 of the Company’s ordinary shares (or o...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US45258H1068
Immix Biopharma, Inc.
IMMX
LISTED
NASDAQ
Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors
News Preview
– Dr. Chang led XOLAIR® from invention through FDA approval and commercialization, exceeding $5 billion in sales so far – ...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Gilead Sciences entscheidet sich für Veeva Vault CRM
News Preview
CRM der nächsten Generation mit umfassenden Funktionen und agentenbasierter KI
PLEASANTON, Calif., 11. September 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute bekannt, dass sich Gilead Sciences für Veeva Vault CRM entschieden hat.
„Gilead ist ein führender Anbieter von lebensverändernden Medikamenten und hat wichtige wissenschaftlich...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program
News Preview
— Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project —
— Areas of Interest Expanded to Include Sleep and Circadian Disturbances Associated With Bipolar I Disorder and/or Schizophrenia —
— Application Period to Run From Sept. 15, 2025 Through Dec. 15, 2025 —
DUBLIN, Sept. 11, 2025 /PRNewswire/ -- Alkermes plc (Nasda...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program
News Preview
— Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project —
— Areas of Interest Expanded to Include Sleep and Circadian Disturbances Associated With Bipolar I Disorder and/or Schizophrenia —
— Application Period to Run From Sept. 15, 2025 Through Dec. 15, 2025 —
DUBLIN, Sept. 11, 2025 /PRNewswire/ -- Alkermes plc (Nasda...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US04746L1044
Athira Pharma, Inc
ATHA
LISTED
NASDAQ
Athira Pharma Announces Reverse Stock Split
News Preview
BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira” or “Company”) (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that it will effect a 10-for-1 reverse stock split of Athira’s issued and authorized...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
News Preview
-- Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth -- -- Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth --...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2025
ISIN: CA90429T1003
Unbuzzd Wellness Inc.
UNBZ
LISTED
CSE
Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2025) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM - the scientifically-proven and game-changing beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms - today announced that the Company will host an Invest...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today provided an operational update and released financial results for the fiscal quarter ended July 31, 2025.
“This quarter marked a defining moment in the history of KalVista with the FDA approval of EKTERLY—the first and only oral on-demand treatment for HAE,” stated Ben Palleiko, CEO of KalVist...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
